Kembali
KLBF - Kalbe Farma

KLBF – Up to IDR1 tn allocation for 2024' capex

03 Januari 2024

KLBF – Up to IDR1 tn allocation for 2024' capex Kalbe Farma (KLBF) plans to allocate around IDR700 bn to IDR1 tn for 2024' capex. KLBF plans to use the capex for; capacity expansion, routine maintenance, and IT improvement. For financial performance, KLBF' 9M23 net profit declined to IDR2.06 tn (-16.9% yoy) due to tough market conditions as it has normalized from high base during pandemic. Yet, KLBF is optimist that the normalization had ended in 2023 and expects better performance (topline and bottomline growth) in 2024. (Source: Kontan)

Related Research

Healthcare
KLBF - 9M25 results came in-line on solid 3Q25 sales growth
Andre Suntono 31 Oktober 2025 Lihat Detail
Consumer
KLBF - Stronger growth and margins expansion
Andre Suntono 12 Juli 2023 Lihat Detail
Healthcare
KLBF - Further growth in ‘25F on better product mix and costs ma...
Andre Suntono 13 Juni 2025 Lihat Detail